GlassScriptPhysician profile
Charles N Boadu
NPI 1861056699
$7,474.29
in general payments reported to CMS, 2019-2025
34 companies · $2,353 in 2025
The $2,353 reported for 2025 was more than what 97% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $1,201 · 2023: $2,018 · 2024: $1,670 · 2025: $2,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,788 · Travel and Lodging: $880 · Education: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,787.85 |
| Travel and Lodging | $880.38 |
| Education | $372.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,367.98 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $1,025.52 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $749.69 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Mamba |
| Janssen Pharmaceuticals, INC | $655.46 | 2021-2024 | Xarelto |
| Medical Device Business Services, INC. | $395.07 | 2023-2024 | Stratafix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.52 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $377.14 | 2022-2025 | Wegovy |
| Abbott Laboratories | $376.38 | 2023-2024 | Mitraclip, Hi-Torque Balance, Perclose Prostyle |
| Actelion Pharmaceuticals US, INC. | $288.03 | 2023-2024 | Opsumit, Uptravi |
| Abiomed | $284.08 | 2023-2025 | Impella |
| Inari Medical, INC. | $258.40 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $214.57 | 2022-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $160.09 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.34 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $124.95 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $94.80 | 2022 | |
| Alnylam Pharmaceuticals INC. | $92.06 | 2025 | Onpattro |
| Amgen INC. | $63.33 | 2021 | |
| Cardiva Medical, INC. | $54.22 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $38.42 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $32.41 | 2023 | Inpefa |
| United Therapeutics Corporation | $30.87 | 2024 | Tyvaso |
| Lilly USA, LLC | $30.70 | 2022-2025 | Zepbound, Mounjaro |
| Cardiovascular Systems INC. | $26.92 | 2022-2023 | Diamondback Coronary |
| Abbvie INC. | $25.11 | 2021 | |
| Terumo Medical Corporation | $24.21 | 2023 | Azur Cx Detachable |
| Regeneron Healthcare Solutions, INC. | $23.90 | 2024 | Evkeeza |
| Radius Health, INC. | $23.38 | 2021 | |
| Corcept Therapeutics | $22.08 | 2022 | |
| Cvrx, INC. | $20.91 | 2025 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $19.33 | 2022 | |
| Philips North America LLC | $18.86 | 2024 | (Dd3) Venous Stent Und |
| Sobi, INC | $18.39 | 2021 | |
| Medtronic, INC. | $18.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Boadu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.